United States · FDA National Drug Code directory
ReVIVOL-XR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43749-432_39db2684-3085-e26e-e063-6394a90ae422
- Product NDC
- 43749-432
- Form
- SUPPOSITORY
- Composition / generic term
- PHENYLEPHRINE HYDROCHLORIDE
- Labeler
- Unipack LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20250401
- Source listing expiry
- 20261231
Source-listed ingredients
- PHENYLEPHRINE HYDROCHLORIDE — 6.25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 24 BLISTER PACK in 1 CARTON (43749-432-01) / 1 SUPPOSITORY in 1 BLISTER PACK · 43749-432-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →